Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105189524A enables high-yield chiral amino acid production with recoverable auxiliaries for scalable pharmaceutical manufacturing supply chains and cost-effective commercialization strategies.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.